Iambic's October 8, 2026 amended S-1 proposes 9,375,000 shares at $15 to $17 on Nasdaq as IAM. The preliminary prospectus leaves the final price and delivery date blank.
https://segmara.com/blog/when-will-iambic-therapeutics-ipo?utm_source=nostr&utm_medium=social&utm_campaign=content_distribution&utm_content=when-will-iambic-therapeutics-ipo
Pre-IPO Share Allocations on Segmara: fund USD portfolio credits via Stripe and purchase or request shares across 60+ private companies in one account.
https://segmara.com/market?utm_source=nostr&utm_medium=social&utm_campaign=content_distribution&utm_content=market
segmara / Segmara
npub1vz…5ncqy
2026-10-30 01:15:40 UTC
Author Public Key
npub1vzerz5wszyw43usdwxzcu0ma374s9sgtqrsjkf8s8j89slyn88tsm5ncqyPublished at
2026-10-30 01:15:40 UTCEvent JSON
{
"id": "09502718f20bd396147cd4aac8dfe70374fccb71579aa3f08928b5fac6c5df4a",
"pubkey": "60b23151d0111d58f20d71858e3f7d8fab02c10b00e12b24f03c8e587c9339d7",
"created_at": 1793322940,
"kind": 1,
"tags": [
[
"t",
"preipo"
],
[
"r",
"https://segmara.com/blog/when-will-iambic-therapeutics-ipo?utm_source=nostr\u0026utm_medium=social\u0026utm_campaign=content_distribution\u0026utm_content=when-will-iambic-therapeutics-ipo"
]
],
"content": "Iambic's October 8, 2026 amended S-1 proposes 9,375,000 shares at $15 to $17 on Nasdaq as IAM. The preliminary prospectus leaves the final price and delivery date blank.\n\nhttps://segmara.com/blog/when-will-iambic-therapeutics-ipo?utm_source=nostr\u0026utm_medium=social\u0026utm_campaign=content_distribution\u0026utm_content=when-will-iambic-therapeutics-ipo\n\nPre-IPO Share Allocations on Segmara: fund USD portfolio credits via Stripe and purchase or request shares across 60+ private companies in one account.\nhttps://segmara.com/market?utm_source=nostr\u0026utm_medium=social\u0026utm_campaign=content_distribution\u0026utm_content=market",
"sig": "30dc08d20552f059403a10c3335372114323722a69bc7ee01e80aae55b4e333e2e4491fc984a62c41a06717c5ea3b16df06415af8a083cfcb228a123a43ea568"
}